SBI Life Insurance Company Share Price

SBI Life Insuran Corporate Action

CMP as on 16-Aug-22 10:00

₹ 1,310.85
24.30 1.89%

Open

₹ 1,289.00

Turnover (lac)

₹ 5,201

Prev. Close

₹ 1,286.55

Day's Vol (shares)

₹ 3,96,779

Day's Range (₹)

₹ 1,287.05
₹ 1,312.00

CMP as on16-Aug-22 9:59

₹ 1,310.95
24.6 1.91%

Open

₹ 1,286.35

Turnover (lac)

₹ 187

Prev. Close

₹ 1,286.35

Day's Vol (shares)

₹ 6,269

Day's Range

₹ 1,286.35
₹ 1,312.10

CMP as on 16-Aug-22 9:59

₹ 1,314.90
26.35 2.04%

Open

₹ 1,287.30

Open Interest(Contracts)

₹ 63,02,250

VWAP

₹ 1,304.51

Day's Vol (shares)

₹ 6,75,750

Day's Range (Ex.Dt. 25 Aug 2022)

₹ 1,287.30
₹ 1,318.00

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 18-Jul-2022 - -
SBI Life Insurance Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2022 inter alia to consider and approve unaudited financial results for the quarter ended June 30 2022. The outcome of the Board Meeting along with the said results will be submitted in accordance with the Listing Regulations. Further pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015 as amended and in continuation to our letter dated June 30 2022 bearing reference number SBIL/F&A-CS/NSE-BSE/2223/89 the trading window will remain closed from July 01 2022 to July 30 2022 (both days inclusive) for declaration of unaudited financial results for the quarter ended June 30 2022. We wish to inform you that the meeting of the Board of Directors of SBI Life Insurance Company Limited commenced at 03:30 P.M. and concluded at 05:50 P.M. on July 28, 2022 (As Per BSE Announcement dated on 28.07.2022)
Board Meeting - 20-Jul-2022 - -
We wish to inform you that the meeting of the Board of Directors of SBI Life Insurance Company Limited held on July 20, 2022 has approved appointment of Mr. Swaminathan Janakiraman (DIN - 08516241) as a Non-Executive, Nominee Director (Nominated by State Bank of India) of the Company with effect from July 20, 2022, subject to regulatory approval. The brief profile of Mr. Swaminathan Janakiraman is enclosed as Annexure I. The details required under Regulation 30 of the Listing Regulations read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015 are given in Annexures. Further, we confirm that Mr. Swaminathan Janakiraman is not debarred from holding the office of Director pursuant to any SEBI order or any other such authority as per the circular of the BSE Limited and the National Stock Exchange of India Limited relating to the Enforcement of SEBI orders regarding appointment of Directors by the listed companies dated June 20, 2018.
Board Meeting - 18-Apr-2022 - -
SBI Life Insurance Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/04/2022 inter alia to consider and approve Audited Financial Result for the quarter and year ended March 31 2022. The outcome of the Board Meeting along with the said results will be submitted in accordance with the Listing Regulations. Further pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015 as amended and in continuation to our letter dated March 31 2022 bearing reference number SBIL/F&A-CS/NSE-BSE/2122/466 the trading window will remain closed from April 01 2022 to April 30 2022 (both days inclusive) for declaration of financial results for the quarter and year ended March 31 2022. We wish to inform you that the meeting of the Board of Directors of the Company commenced at 12:00 P.M. and concluded at 02:45 P.M. on April 28, 2022 which inter-alia approved the Audited Financial Results for the quarter and year ended March 31, 2022. Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and other applicable requirements, a copy of the Audited Financial Results for the quarter and year ended March 31, 2022 together with the Independent Auditors Report in the prescribed format is enclosed. A copy of press release being issue in this connection is also enclosed. We would like to state that M/s. S. K. Patodia & Associates, Chartered Accountants and M/s. S. C. Bapna & Associates, Chartered Accountants, joint statutory auditors of the Company, have issued audit reports with unmodified opinion. We request to you to kindly take the above information on record. (As per BSE Announcement Dated on 28/4/2022)
Board Meeting - 15-Mar-2022 - -
SBI Life Insurance Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/03/2022 inter alia to consider and approve payment of interim dividend for the Financial Year 2021-22 if any. The Record date of March 30 2022 has been fixed for the purpose of entitlement of the shareholders to the interim dividend for the Financial Year 2021-22 if any declared by the Board of Directors of the Company. SBI Life Insurance Company Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 22, 2022, has declared an interim dividend of Rs. 2/- (Two rupees only) per equity share with a face value of Rs.10 each (i.e. 20%) for the Financial Year 2021-22. Pursuant to Regulation 30(6), 42 and 43 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we wish to inform that the meeting of Board of Directors of SBI Life Insurance Company Limited commenced at 05:45 P.M and concluded at 06:30 P.M. on March 22, 2022 has declared an interim dividend of Rs 2/- (Two rupees only) per equity share with a face value of Rs.10 each (i.e. 20%) for the Financial Year 2021-22. The interim dividend for Financial Year 2021-22 will be paid to those shareholders whose names appear on the Register of Members of the Company or in the records of the Depositories as beneficial owners of the shares determined with reference to the Record Date of March 30, 2022, already announced for the purpose vide our letter no: SBIL/F&ACS/ NSE-BSE/2122/439 dated March 15, 2022. The aforesaid Interim Dividend will be paid to the Shareholders on or before April 20, 2022. (As Per BSE Announcement Dated on 22.03.2022)
Board Meeting - 13-Jan-2022 - -
Quarterly Results SBI Life Insurance Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/01/2022 ,inter alia, to consider and approve financial results for the quarter & nine months ended December 31, 2021. The outcome of the Board Meeting along with the said results will be submitted in accordance with the Listing Regulations. Further, pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended and in continuation to our letter no. SBIL/F&A-CS/NSE-BSE/2122/287 dated December 31, 2021, the trading window will remain closed from January 01, 2022 to January 23, 2022 (both days inclusive) for declaration of financial results for the quarter & nine months ended December 31, 2021. You are requested to kindly take the same on records. We wish to inform you that the meeting of the Board of Directors of the Company commenced at 11.30 A.M and concluded at 02:50 P.M on January 21, 2022 which inter-alia approved the unaudited Condensed Financial Results for the quarter and nine months ended December 31, 2021. Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and other applicable requirements, a copy of the unaudited financial results for the quarter and nine months ended December 31, 2021 together with the Limited Review Report in the prescribed format is enclosed. A copy of press release being issue in this connection is also enclosed. We request to you to kindly take the above information on record. (As Per BSE Announcement dated on 21.01.2022)
Board Meeting - 18-Oct-2021 - -
Quarterly Results We wish to inform you that the meeting of the Board of Directors of the Company commenced at 12:00 Noon and concluded at 03:20 P.M. on October 27, 2021 which inter-alia approved the Audited Financial Results for the quarter and half year ended September 30, 2021. Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and other applicable requirements, a copy of the audited financial results for the half year ended September 30, 2021 together with the Audit Report in the prescribed format is enclosed. A copy of press release being issue in this connection is also enclosed. We request to you to kindly take the above information on record. (As Per BSE announcement Dated on 27.10.2021)
Board Meeting - 24-Aug-2021 - -
We wish to inform you that the meeting of the Board of Directors of SBI Life Insurance Company Limited held on August 24, 2021 has approved the following: A) Appointment of Ms. Usha Sangwan as an Additional Independent Director B) Annual General Meeting on September 24, 2021 We request to you to kindly take the above information on record.
Open ZERO Brokerage Demat Account Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity